Most people now encounter cosmetic treatment first on social media, and much of what they see is advertising that has not been labelled as advertising. The rules are not ambiguous. Enforcement depends on complaints, and complaints depend on people knowing the rules exist.
When a post is an advertisement
The CAP Code applies to marketing communications, which includes content on a brand's own social channels and content by a third party where there is both payment and control by the advertiser. Payment does not have to be cash. A free treatment, a discounted treatment, a gifted product or an ongoing arrangement is consideration.
Where a post is an advertisement it must be obviously identifiable as such, before anyone engages with it. In practice that means a clear label at the start, not a hashtag buried among twenty others or hidden behind a more button. The ASA has repeatedly ruled on the placement and prominence of these labels.
Alongside the CAP Code, the Consumer Protection from Unfair Trading Regulations 2008 prohibit falsely representing oneself as a consumer, which is what undisclosed advertising does.
The medicines problem, which nobody mentions
Prescription only medicines may not be advertised to the public in the UK. Botulinum toxin products are prescription only medicines. A post naming a toxin brand, tagging it, or displaying its packaging, in promotional content, engages that prohibition.
This is the single most commonly breached rule in cosmetic social media, and it is breached by clinics as well as by influencers. It is also the easiest to spot, because it requires no judgement about whether a result is exaggerated. The brand name is either there or it is not.
What you are entitled to as a reader
- Advertising that is obviously identifiable as advertising, under the CAP Code.
- Not to be addressed by someone falsely presenting themselves as an ordinary consumer, under the Consumer Protection from Unfair Trading Regulations 2008.
- Results content that does not exaggerate or present atypical outcomes as typical.
- Freedom from advertising of prescription only medicines to the public.
- To report any of the above to the ASA, free, without being a customer.
Free or discounted treatment in exchange for a post is payment, and triggers the disclosure requirement.
Results content
The same rules on before and after imagery apply on social media as anywhere else. Results must not be exaggerated, atypical results must not be presented as typical, and comparisons must be genuine. Video adds new problems: lighting changes between clips, camera lens differences, and platform beauty filters that may be applied by default without the poster consciously choosing them.
A filter applied to an after clip and not to a before clip is a misleading comparison whether or not anyone intended it. See what the rules require of before and after imagery.
A post presented as a personal experience that also contains a discount code. A code is a commercial arrangement. Content that reads as a friend's recommendation while functioning as an affiliate link is precisely the practice the disclosure rules exist to prevent.
How to read a post critically
- Look for a label at the very start: an advertisement label, a paid partnership tag, or a clear statement of the relationship. Absence where a relationship exists is a breach.
- Look for a discount code or a link. Both indicate a commercial arrangement.
- Look for the timeline. Content posted on the day of treatment shows swelling, not a result.
- Look for who is speaking. A registered clinician making a claim is subject to their regulator's standards. A creator with no clinical training is subject to neither those nor any professional accountability.
- Look for what is not shown. Recovery, cost, maintenance interval, and the possibility of complications are the four things almost never included.
Clinicians posting on social media
Registered professionals carry their regulator's standards with them onto social platforms. Professional guidance addresses promotion, testimonials and behaviour that could bring the profession into disrepute, and content that would breach the standards in a leaflet breaches them in a video.
This means a poorly compliant clinical account is reportable twice: to the ASA for the marketing, and to the regulator for the professional conduct. Both routes are free.
Content that reaches young people
Marketing rules restrict advertising cosmetic interventions to under 18s, and in England the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 makes administration for cosmetic purposes to under 18s a criminal offence. Content on platforms with large under 18 audiences engages both. If you see cosmetic treatment promoted in a way that appears aimed at young people, that is specifically reportable. See our guide to the Act.
Reporting it
The ASA takes complaints from anyone who has seen a marketing communication. Screenshot the post with the date and the account name before reporting, because it may be deleted. You do not have to be a customer, it is free, and rulings are published and read within the industry.
For a registered professional, the regulator route runs in parallel. Both are set out in how to complain and to whom.